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Type VII collagen as component of anchoring ﬁbrils plays an important role in skin architecture,
however, no detailed structural information is available. Here, we describe the recombinant expres-
sion, isotope labeling, and 1H, 15N, 13C chemical shift assignment of a subdomain of the murine type
VII collagen – the von-Willebrand-factor-A-like domain 2 (mvWFA2). vWFA2 interacts with type I
collagen and plays a central role in certain skin blistering diseases. Based on these assignments a
secondary structure prediction was performed showing a properly folded protein. An interaction
of mvWFA2 with its neighboring domain mFNIII-9 was characterized with NMR spectroscopy and
SPR.
Structured summary of protein interactions:
mFNIII-9 and mvWFA2 bind by nuclear magnetic resonance (View interaction)
mvWFA2 binds to mFNIII-9 by surface plasmon resonance (View interaction)
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Type VII collagen (Col7) is the main component of the anchoring
ﬁbrils, connecting the basal lamina with the tissue beneath by
interacting with other collagen types and parts of the extracellular
matrix [1,2].
Col7 is a homotrimer consisting of one central collagenous
domain interrupted by a short non-collagenous region. The central
domain is ﬂanked by two non-collagenous domains. The C-terminal
non-collagenous domain 2 (NC-2) contains conserved cysteine
residues which accompany an antiparallel assembly of these colla-
gen molecules. In contrast the N-terminal non-collagenous domain
1 (NC-1) consists of several subdomains with high homologies to
adhesion proteins. The C-terminal subdomain of NC-1 reveals high
homology to von-Willebrand-factor A and is called von-Wille-
brand-factor-A like domain 2 (vWFA2) [3]. A schematic representa-
tion of a single Col7 a-chain forming a homotrimer is shown in
Fig. 1.chemical Societies. Published by E
ermolysis bullosa acquisita;
, non-collagenous domain 1;
on resonance; TALOS, torsion
similarity; mvWFA2, murine
methylsilyl)propionic acid-d4
k.de (K. Seeger).Investigations have shown that vWFA2 plays a crucial role for
binding to type I collagen but also for interactions with other com-
ponents of the extracellular matrix [2,4]. It is assumed that these
connections contribute to skin stability. However, detailed knowl-
edge of the skin architecture and the role of Col7 are still sparse
and no high resolution structural information at atomic level is
available.
Col7 is involved in different skin blistering diseases. A heritable
form is caused by mutations in type VII collagen, which are also
located within vWFA2 [5]. Loss of tolerances to Col7 leads to the
autoimmune skin blistering disease epidermolysis bullosa acquisi-
ta (EBA) characterized by autoantibodies against Col7. During the
course of disease the dermis separates from the epidermis result-
ing in blisters and lesions [6]. Former investigations have shown
that antigenic epitopes can be found also in vWFA2 [7,8]. So far
only little is known about the exact contribution of this domain
in the architecture of the extracellular matrix and its role in devel-
oping EBA.
Therefore, structural investigations of the murine von-
Willebrand-factor-A-like domain 2 (mvWFA2) should help to gain
more insight into the connection of the skin layers and the role of
this domain in skin blistering diseases.
Nuclear magnetic resonance (NMR) spectroscopy is advanta-
geous for structural investigationsdue to itspossibilityof investigat-
ing dynamic systems as interactionswith possible ligands. Based on
NMR resonance assignment secondary structure elements havelsevier B.V. All rights reserved.
Fig. 1. Scheme of an a-chain of type VII collagen. Three identical a-chains build up Col7 forming anchoring ﬁbrils. Each chain consists of CMP: cartilage-matrix-protein-like
domain; FNIII-(1–9): ﬁbronectin like domains; vWFA2: von-Willebrand-factor-A-like domain 2.
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from shift and sequence similarity+ (TALOS)+ [9]. Additional infor-
mation has been achieved by 3J-H(N)–H(a)-coupling constants and
hydrogen–deuterium exchange. The experimental data are in good
agreement with a homology model. Interestingly, an interaction
with its neighboring domain the murine ﬁbronectin-III-like domain
9 (mFNIII-9) has been shown the ﬁrst time andwas characterized by
surface plasmon resonance (SPR) and NMR spectroscopy.
2. Methods
2.1. Protein expression and puriﬁcation
A codon optimized sequence of mvWFA2 and of mFNIII-9 of
Col7 was commercially synthesized (Mr. Gene, Regensburg, Ger-
many) and cloned in pTWIN1 (NEB, Frankfurt, Germany). Cloning
of the genes differs in the position of their intein afﬁnity-tags.
Whereas mvWFA2 has an N-terminal afﬁnity-tag the afﬁnity-tag
of mFNIII-9 is C-terminal. Protein expression in Escherichia coli
ER2566 and puriﬁcation of both proteins followed the IMPACT™-
TWIN protocol (NEB). mvWFA2 has been labeled uniformly with
15N and 13C according to Marley et al. [10]. Selective labeling for
the amino acids A, R, and V was done according to Griffey et al.
[11]. Cloning, expression and puriﬁcation of mFNIII-9 was per-
formed analog to mvWFA2.
2.2. NMR spectroscopy and structure prediction
NMR experiments have been performed on a Bruker Avance
DRX 500 spectrometer equipped with a TCI cryoprobe at 298 K in
10 mM sodium phosphate buffer, pH 7.4 and 10% D2O. 3-(trimeth-
ylsilyl)propionic acid-d4 sodium salt (TSP-d4) was added as internal
chemical shift reference. 13C and 15N chemical shifts have been ref-
erenced using the absolute frequency ratios [12]. A set of three
dimensional triple resonance experiments namely CBCACONH,
HNCA, HCCCONH, HBHACONH, HNCOCA, HNCO, HNHA and
NOESY-HSQC have been performed. 1H,15N-HSQC spectra of
15N–13C mvWFA2 in 100% D2O have been recorded additionally
to identify slow exchanging amide protons. 1H,15N-HSQC spectra
have been recorded immediately after 1H–2H exchange and 3 days
later.
Spectra processing was done with Bruker Topspin 2.0. For data
analysis and resonance assignment Sparky has been used. Scalar
coupling constants have been calculated for information of ﬂexibil-
ity of mvWFA2 from an HNHA experiment according to Vuister and
Bax [13]. Secondary structure determination has been performed
with TALOS+ on the eNMR web portal [9,14].
The interaction site of mvWFA2 with mFNIII-9 was determined
via chemical shift mapping as described by Farmer et al.
Dd ¼ ½ðdbHN  dfHNÞ2 þ ð0:17ðdbN  dfNÞÞ20:5 with b and f representing
bound and free state [15]. The molar ratio of mvWFA2 to mFNIII-
9 was approximately 1:2 with a concentration of 100 lM labeled
mvWFA2.
A three dimensional homology model has been obtained from
Swiss Model [16]. The homology model was built on the basis of
an alignment of the amino-acid sequence of mvWFA2 with a sim-
ilar protein of known structure. This template protein is the crystalstructure of the von-Willebrand-factor-A3 domain in complex with
a Fab fragment of IgG RU5 (PDB: 1FE8C) and the overall sequence
identity is 20.1%.
2.3. SPR binding assay
A BIAcore 3000 has been used for SPR measurements. mvWFA2
was dissolved in 10 mM sodium acetate buffer pH 4 and immobi-
lized on a CM5 sensor chip resulting in 6000 resonance units. This
would correspond to a theoretical RUmax of 1156 for mFNIII-9.
Binding experiments were performed in triplicate at room temper-
ature in 10 mM sodium phosphate buffer pH 7.4. Dilutions of
mFNIII-9 ranged from 100 lM to 2 mM. The KD was determined
via steady-state curve ﬁtting analysis of BIAevaluation software
assuming an 1:1 binding stoichiometry.
3. Results and discussion
3.1. Chemical shift assignment
Expression and puriﬁcation of 15N and 15N, 13C-labeled
mvWFA2 yielded a single band in the SDS–PAGE (Supplementary
data) with a typical overall yield of 19 mg protein per liter minimal
medium. mvWFA2 shows a well-resolved 1H,15N-HSQC spectrum
indicating that the recombinant mvWFA2 is properly folded
(Fig. 2). The sample was stable over several months as identical
spectrum patterns attest. Backbone assignments were obtained
using standard triple resonance experiments. The assignment of
the backbone chemical shifts is 96% complete. The N-terminal res-
idues belonging to the afﬁnity-tag could not be assigned due to
ﬂexibility. Solely from the chemical shifts a ﬁrst structural charac-
ter a disulﬁde bridge was identiﬁed. SDS–gel electrophoresis under
non-reducing conditions revealed those to be intramolecular (data
not shown). These chemical shift assignments present the initial
point for structure determination of mvWFA2 and for protein–pro-
tein interaction studies.
3.2. Secondary structure prediction
Based on chemical shift assignments a secondary structure pre-
diction of mvWFA2 employing TALOS+ via the eNMR web-portal
was performed [9,14]. This program predicts torsion angles from
Ca, Cb, N, H and Ha NMR backbone chemical shifts (see Supplemen-
tary data). The resulting prediction for mvWFA2 is consistent with
idealized secondary structure elements for the majority of the res-
idues. Only a short region in the middle part (residues 78–87) is
less well deﬁned making a clear conclusion difﬁcult. Overall a b-
strand is predicted for this region.
A comparison of the derived prediction with the homologous
von-Willebrand-factor-A3 domain (PDB: 1AO3) matches well. It
shows a similar distribution of a-helical and b-sheet sequences
but they differ in length of secondary structure elements (Fig. 3c).
3.3. Coupling constants
With the help of an HNHA spectrum scalar coupling constants
have been determined. These permit also to draw conclusions
Fig. 3. Secondary structure prediction and interaction of mvWFA2 with mFNIII-9. (a) 3J HN–Ha coupling constants obtained from HNHA spectrum of mvWFA2. Horizontal
lines represent the cut-off values for secondary structure elements, i.e. <6 Hz for a-helical regions and >8 Hz for b-strands, (b) chemical shift variation upon binding mFNIII-9
to mvWFA2 and (c) secondary structure illustration of mvWFA2 compared to homologous vWF.
Fig. 2. 1H,15N-HSQC spectrum of mvWFA2 in 10 mM sodium phosphate buffer pH 7.4 at 298 K.
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6 Hz are typical for a-helical regions while J couplings larger than
8 Hz are characteristic for b-sheets. The calculated coupling con-
stants are altogether in good agreement with the secondary struc-
ture prediction of TALOS+ as shown in Fig. 2a. Merely, a part in the
middle of the protein (residue 78–87) disagrees with the structure
prediction suggesting an a-helical region instead of a b-strand
according to TALOS+.
Also the TALOS+ prediction for this part was not well deﬁned,
thus this protein region may be in a ﬂexible loop.
3.4. Hydrogen–deuterium exchange
To identify slow exchanging amide protons a 1H,15N-HSQC was
recorded immediately after 1H–2H exchange and 3 days later. Bothspectra showed few peaks and the number of peaks vary only
slightly. We conclude that most amide protons are solvent accessi-
ble whereas amide protons showing a slow exchange are part of
the inner, hydrophobic core of the protein. At this stage the homol-
ogy model of mvWFA2 was used to interpret the data. According to
the homology model these slow exchanging residues in fact reside
in the core of the protein and are part of the b-sheets as illustrated
in Fig. 4a. The experimental results are consistent with our model.
3.5. Interaction of mvWFA2 with mFNIII-9
The non-collagenous domain 1 mediates the interaction with
other skin components such as type I collagen or laminin 322.
For a deeper understanding of these interactions knowledge of
the quaternary structure of Col7 is required. To obtain a more
Fig. 4. Homology model of mvWFA2 generated with Swiss Model [16] (a) slowly exchanging amide protons are illustrated in blue. These protons belong to D8, V9, V10, F11,
L12, L13, L33, V34, V114, M115, V116, L117, L118, V119, M142 and F167 and (b) binding site of mFNIII-9, residues are colored according the chemical shift changes (red:
Pstrong; orange: Pintermediate; yellow: Pweak changes in chemical shifts).
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tions of mvWFA with other Col7 domains have to be performed.
Thus the interaction between mvWFA2 and its neighboring do-
main mFNIII-9 was analyzed.
A 1H,15N-HSQC spectrum of 15N-labeled mvWFA2 with an
excess of unlabeled mFNIII-9 shows a shift for certain residues. A
chemical shift mapping identiﬁed those residues with signiﬁcant
alteration of the chemical shift. We conclude that these residues
interact with the mFNIII-9 domain.
The spectra indicate fast exchange at the chemical shift time-
scale which points to a weak binding afﬁnity of mFNIII-9 to
mvWFA2. In order to quantitate the interaction of mFNIII-9 and
mvWFA2 we employed SPR. The determined KD is 0.8 ± 0.3 mM
and in agreement with the NMR experiments. The affected resi-
dues have been mapped onto the homology model of mvWFA2
as shown in Fig. 4b. The majority of the residues are located at
the same area of the model thus identifying the interaction site
of mvWFA2 with mFNIII-9. Residues showing small chemical shift
variations at sites far away from the interaction site are considered
to be not part of the binding surface. The binding site for mFNIII-9
comprises the ﬁrst and the last helix of mvWFA2 that is also in
concordance with the homology model. This ﬁnding is further sup-
ported in a biological context because in the native Col7 molecule
the FNIII-9 domain resides at this site. However, the most affected
residues in the homology model point inwards of the protein indi-
cating a slight different conformation of the helices in vivo.
Comparison of our model with other homologous collagen
binding proteins shows that the putative binding sites for type I
collagen as well as the cell adhesion mediating RGD-motif are
opposite to the mFNIII-9 interaction site. This suggests that
mFNIII-9 is not involved in interactions with type I collagen which
is supported by Chen et al. who showed that the FNIII repeats 7–9
participate in binding laminin 322 [17].
Successful expression, puriﬁcation and NMR resonance assign-
ment of the von-Willebrand-factor-A-like domain 2 of murine type
VII collagen is the basis for detailed structural information on Col7.
For the ﬁrst time a speciﬁc interaction between mvWFA2 and
mFNIII-9 was shown and the binding site for mFNIII-9 on mvWFA2
was identiﬁed. The binding afﬁnity is weak but in the native mol-
ecule this interaction might be much more important due to direct
connection of the two domains. This has implication for the
quaternary structure of type VII collagen. The binding site does
not overlap with potential collagen I binding areas. However, the
mFNIII-9 mvWFA2 interaction might be inﬂuenced by binding of
components of the extracellular matrix and thus the quaternary
structure of type VII collagen can be affected. Due to the centralrole of Col7 in skin architecture disturbance of these structures
either via mutations or autoantibodies leads to severe skin blister-
ing diseases.
3.6. Outlook
These ﬁndings are the basis for further structural analysis and
interaction studies with type I collagen and antibodies against
mvWFA2. This will ultimately lead to a better understanding of
pathogenesis of heritable and acquired skin blistering diseases.
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